There were 1,731 press releases posted in the last 24 hours and 359,527 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image